Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lupin Slapped With Fresh FDA Warning Letter

24 Sep 2019

• By Penelope MacRae

Warning — Lupin has received a further FDA warning • Source: Shutterstock

Related Content

Lupin Q1 Profit Up 50% But Regulatory Overhang, Slow Product Scale-Up Sparks Concern

13 Aug 2019

FDA Action Awaits Lupin Sites As Compliance Cloud Lingers

15 Mar 2019

Boehringer Ingelheim Snaps Up Lupin's MEK Inhibitor For Difficult-To-Treat Cancers

04 Sep 2019

Related Companies

Lupin Limited

Additional Topics

United States Manufacturing Compliance FDA BioPharmaceutical

More from Manufacturing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.